DexCom, Inc., of San Diego, announced that it has received approval to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter.


Patients will be able to manually enter calibration data directly into the system without use of a connection cable.

Continue Reading


“We continue to believe that the introduction of new, more convenient products is key to the development of the continuous glucose monitoring category,” said Terrance H. Gregg, DexCom’s president and chief executive officer. The company expects to introduce this feature to new patients near the end of the first quarter of the year and upgrade existing patients during the second quarter.